Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab

Published:2021-12-16 Issue: Volume: Page:
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Experimental Derm

Author:

Zengarini C.¹²^ORCID,Roda M.³²^ORCID,Schiavi C.³²,Bruni F.¹²^ORCID,Bardazzi F.¹²,Bellusci C.³²,Raone B.¹

Affiliation:

1. Dermatology Unit IRCCS Policlinico Sant'Orsola Hospital BolognaItaly

2. Department of Experimental, Diagnostic and Specialty Medicine (DIMES) University of Bologna Bologna Italy

3. Ophthalmology Unit IRCCS Policlinico Sant'Orsola Hospital Bologna Italy

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15000

Reference5 articles.

1. Atopic dermatitis phenotypes in childhood;Ricci G;Ital J Pediatr,2014

2. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II;Wollenberg A;J Eur Acad Dermatol Venereol,2018

3. Conjunctivitis in patients with atopic dermatitis treated with dupilumab;Ferreira S;Drugs Context,2020

4. Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real‐life effectiveness;Pelaia C;Ther Adv Respir Dis,2018

5. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party;Williams HC;Br J Dermatol,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neue und zukünftige Therapieansätze in der Behandlung der allergischen Konjunktivitis;Die Ophthalmologie;2024-02-16

2. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape;Survey of Ophthalmology;2023-10

3. Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab;World Allergy Organization Journal;2023-06

4. Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye;Allergology International;2023-04

5. Immunobiologicals and ocular surface disease;Current Opinion in Allergy & Clinical Immunology;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3